CClinicalTrials.gg
CompletedNCT04866823Updated Apr 29, 2025Results posted

Meals for Moms: Medically-Tailored Meals for Women Who Had Gestational Diabetes

An interventional study of Medically Tailored Meals in Diabetes, Gestational, Gestational Weight Gain and Postpartum Weight Retention, sponsored by Wake Forest University Health Sciences. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-04-29.

Sponsored by Wake Forest University Health Sciences · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The purpose of this research study is to test whether delivery of medically tailored meals (meals designed specifically to be healthy) can be used to help reduce high blood sugar after delivery of a baby. Participants will be recruited and consented during the third trimester of pregnancy but will begin study activities after delivery. Participants will complete a series of questionnaires on demographics, health history, home environment, overall and financial stress, plans for weight loss and infant feeding, and food insecurity. Participants will also be asked to wear continuous glucose monitors for two separate 14-day periods (within 2 weeks of delivery and at 3 months). All participants will receive weekly emails with educational videos and 3 virtual visits with a member of the study team and will also be randomly assigned to an intervention or comparison group. In the intervention, participants will receive weekly meal deliveries of 10 pre-prepared meals from Providence Community Kitchen (local company in Winston-Salem, NC) that are calorically restricted and appropriate for post-partum women with a history of gestational diabetes and who may be breast-feeding. Women in the control condition will receive written resources on self-care, nutrition, and physical activity appropriate for post-partum women who had gestational diabetes.

Read the detailed description

Pregnancy and delivery can function as a "stress test" for future development of cardiovascular disease and metabolic disorders, with gestational diabetes and excessive weight gain during pregnancy leading to worse outcomes later in a mother's life. The prevalence of both conditions continues to increase with the obesity epidemic, highlighting the urgent need for successful interventions to reverse maternal weight gain and promote normal blood sugars. The early postpartum period provides a critical opportunity to address diet behaviors that are related to both weight and diabetes. Postpartum medically-tailored meal delivery is a novel approach that may allow for improved blood sugar control and weight loss in a traditionally hard-to-engage patient population. There is currently no available data on the cost, feasibility, or effectiveness of providing medically-tailored meals to postpartum women. This is a pilot study of medically-tailored meals for new mothers whose pregnancies were complicated by gestational diabetes, and whose total gestational weight gain exceeded recommendations. Study will enroll 30 women with gestational diabetes and excessive gestational weight gain late in the third trimester of a singleton pregnancy. Data collection and intervention activities will begin after delivery. All participants will wear a continuous glucose monitor for baseline (first 2 weeks after delivery) and at follow up (after 3 months). Participants will also completed self-administered questionnaires, receive weekly informational videos by email, and have 3 monthly in-person check-ins with a member of the study team. Twenty participants will be randomly assigned to a medically-tailored meals intervention and 10 to a usual-care comparison group. A local community-based program will prepare and deliver 10 medically-tailored meals per week to intervention participants for their first 3 months postpartum.

02

Conditions studied

  • Diabetes, Gestational
  • Gestational Weight Gain
  • Postpartum Weight Retention

Keywords

  • Lifestyle Intervention
  • Weight-Loss
  • Self-Care
03

In context

Diabetes, Gestational

842 studies on the registry are indexed under Diabetes, Gestational; 198 are open to participants now.

This study's enrollment of 12 is below the median of 110 across 550 interventional studies indexed under Diabetes, Gestational.

Browse Diabetes, Gestational studies →

Lead sponsor

Wake Forest University Health Sciences is the lead sponsor of 1,320 studies on the registry; 199 are open to participants now.

Of its 323 completed or terminated interventional studies of FDA-regulated products, 243 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Demographics: Women 18 years of age and older who reside in Forsyth County, NC
  • Pregnancy: Currently 24 or more weeks into a singleton pregnancy
  • Clinical evidence of gestational diabetes mellitus (GDM) defined as either 3-hour oral glucose tolerance test (OGTT) results obtained in the second trimester of pregnancy that show at least 2 abnormal values or a diagnosis of "gestational diabetes" included on the Problem List in medical record during current pregnancy, regardless of OGTT values
  • Excessive gestational weight gain: Most recent weight exceeds predicted weight gain for current weeks gestational age defined as pre-pregnancy Body mass index (BMI) of 30 kg/m2 or more and weight at most recent clinical visit 20+ pounds over pre-pregnancy weight or pre-pregnancy BMI of 25-29.9 kg/m2 and weight at most recent clinical visit 25+ pounds over pre-pregnancy weight
  • English Proficiency: Able to read/understand English at or above a level sufficient to comprehend recruitment, informed consent, and intervention materials.
  • Access to a smart phone/tablet/computer capable of connecting to video calls or teleconferencing software.
  • Willingness to Accept Randomization: Prospective participants must be willing to accept randomization to either the medically tailored meal intervention or the comparison intervention condition.

Exclusion criteria

Exclusion Criteria:

  • Clinical history of diabetes (type 1 or 2) pre-pregnancy
  • Non-singleton pregnancy
  • Other chronic diseases or medical conditions that would increase risk or make participation otherwise unsafe, including special dietary needs. A clinician investigator will review the medical record for all potential participants to determine if any such conditions exist.
  • Known food allergies of sensitivities. Potential participants who report special dietary requirements including vegetarians, vegans, those who follow kosher or other specialized diets will be excluded due to the small nature of this pilot study.
  • History of allergic skin reaction to adhesive tape
  • Unable or unwilling to wear a continuous glucose monitor (CGM) device
  • Is scheduled for an MRI during the study weeks, making use of the CGM device unsafe
  • Other: Conditions/criteria likely to interfere with participation and acceptance of randomized assignment, including the following: inability/unwillingness to give informed consent, major psychiatric or cognitive problems (schizophrenia, dementia, self-reported substance or alcohol abuse), participation in another research study that would interfere with Meals for Moms
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
12 participants (actual)

Study arms

  • Experimental
    Medically Tailored Meals

    A series of medically tailored meals appropriate for women with gestational diabetes will be developed in partnership with chefs from a local community kitchen and catering company. Meals will create a slight caloric deficit in order to promote gradual weight loss, but with sufficient energy intake and macronutrient balance to allow breastfeeding. These meals will be roughly 40% carbohydrate, 30% protein, and 30% fat in composition. Study Team will plan up to 20 unique lunch and dinner meals for the series. Each meal will be prepared to be between 450-600 kcal and to contain 6 ounces of protein, 4 ounces of vegetable and I cup of whole grain (at a minimum). Participants will receive detailed recipe cards and nutrition information with each meal. In addition to receiving the medically tailored meals, participants will be advised to supplement their own breakfast +/- snacks to reach a total daily calorie goal determined by starting BMI category.

    Behavioral: Medically Tailored Meals

  • No intervention
    Usual Care Comparison Group

    Participants in this group will receive written materials on self-care, nutrition, and physical activity in the postpartum period and community resources for healthy living.

Interventions

  • BehavioralMedically Tailored Meals

    Participants will receive weekly meals (20 per week) prepared by a local community kitchen and catering group. Each week, 10 dinners and 10 lunches will be delivered to the participant's home with instructions for storage, re-heating, recipes, and nutritional information.

06

What researchers measure

Primary outcomes

  1. Number of Meals Successfully Ordered and Delivered

    Determine the percent of meals successfully ordered \& delivered in the intervention group

    Time frame: 3 months

  2. Number of Dollars Cost

    Determine the total cost across all participants for the medically tailored meal program per participant assuming 20 meals per week provided to each participant for 12 weeks.

    Time frame: 3 months

  3. Days of Continuous Glucose Monitoring in Postpartum Mothers

    Tracking the number of days the continuous glucose monitors were worn (of 14 total possible) at baseline.

    Time frame: 14 day period assessed at baseline

  4. Days of Continuous Glucose Monitoring in Postpartum Mothers

    Tracking the number of days the continuous glucose monitors were worn (of 14 total possible) at 3 months.

    Time frame: 3 months

07

Results

Posted Feb 10, 2025

Participant flow

Due to recruitment limitations, we did not include a comparison group.

Participant flow — Overall Study
MilestoneMedically Tailored MealsUsual Care Comparison Group
Started120
Completed90
Not completed30

Outcome measures

PrimaryNumber of Meals Successfully Ordered and Delivered

Determine the percent of meals successfully ordered \& delivered in the intervention group

Time frame:
3 months
Reported as:
Count of units · meals
Number of Meals Successfully Ordered and Delivered
mealsMedically Tailored MealsUsual Care Comparison Group
Number of Meals Successfully Ordered and Delivered2880—
PrimaryNumber of Dollars Cost

Determine the total cost across all participants for the medically tailored meal program per participant assuming 20 meals per week provided to each participant for 12 weeks.

Time frame:
3 months
Reported as:
Number · Number of dollars cost
Number of Dollars Cost
Number of dollars costMedically Tailored MealsUsual Care Comparison Group
Number of Dollars Cost1800.0—
PrimaryDays of Continuous Glucose Monitoring in Postpartum Mothers

Tracking the number of days the continuous glucose monitors were worn (of 14 total possible) at baseline.

Time frame:
14 day period assessed at baseline
Reported as:
Mean · Number of Days
Days of Continuous Glucose Monitoring in Postpartum Mothers
Number of DaysMedically Tailored MealsUsual Care Comparison Group
Days of Continuous Glucose Monitoring in Postpartum Mothers13 (6 to 14)—
PrimaryDays of Continuous Glucose Monitoring in Postpartum Mothers

Tracking the number of days the continuous glucose monitors were worn (of 14 total possible) at 3 months.

Time frame:
3 months
Reported as:
Mean · days
Days of Continuous Glucose Monitoring in Postpartum Mothers
daysMedically Tailored MealsUsual Care Comparison Group
Days of Continuous Glucose Monitoring in Postpartum Mothers11.43 (1 to 14)—

Adverse events

Collected over 3 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Medically Tailored Meals0/12 (0%)0/12 (0%)0/12 (0%)
Usual Care Comparison Group———

Baseline characteristics

Due to recruitment limitations, we did not inlcude a comparison group.

Age, Categorical
Age, Categorical(Participants)Medically Tailored MealsUsual Care Comparison GroupTotal
<=18 years0—0
Between 18 and 65 years12—12
>=65 years0—0
Age, Continuous
Age, Continuous(years)Medically Tailored MealsUsual Care Comparison GroupTotal
Mean35 ± 5—35 ± 5
Sex: Female, Male
Sex: Female, Male(Participants)Medically Tailored MealsUsual Care Comparison GroupTotal
Female12—12
Male0—0
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Medically Tailored MealsUsual Care Comparison GroupTotal
Hispanic or Latino6—6
Not Hispanic or Latino6—6
Unknown or Not Reported0—0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Medically Tailored MealsUsual Care Comparison GroupTotal
American Indian or Alaska Native0—0
Asian2—2
Native Hawaiian or Other Pacific Islander0—0
Black or African American5—5
White3—3
More than one race2—2
Unknown or Not Reported0—0
Region of Enrollment
Region of Enrollment(participants)Medically Tailored MealsUsual Care Comparison GroupTotal
United States12—12
08

Study locations

1 site
  • Wake Forest Baptist Health
    Winston-Salem, North Carolina 27101, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · May 23, 2022
  • Informed consent form · May 23, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04866823
Lead sponsor
Wake Forest University Health Sciences
Collaborators
North Carolina Diabetes Research Center, University of North Carolina, Chapel Hill
Responsible party
Sponsor
First posted
Apr 30, 2021
Start date
Oct 20, 2021
Primary completion
Jan 17, 2023
Completion
Jan 17, 2023
Results posted
Feb 10, 2025
Last update
Apr 29, 2025

Study contacts

Morgana Mongraw-Chaffin
principal investigator · Wake Forest University Health Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion